Skip to content

Use of red laser and chamomile in the treatment of oral ulcers in children and adolescents with cancer

Use of photobiomodulation and chamomile in the treatment of oral mucositis in children and adolescents with cancer: a randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3272v32
Enrollment
Unknown
Registered
2021-12-20
Start date
2019-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatitis, Oral mucositis

Interventions

Group A: Photobiomodulation in the red spectrum of action. Group B: Photobiomodulation in the red spectrum of action associated with the topical application of chamomile orabase ointment in the areas
SILVA, V.C.R. et al., 2018). Before each use, the laser tip will be disinfected with 70% alcohol and coated with a plastic barrier. In addition, there will be a weekly review on the calibration of the
E02.594.540

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Hospital Universitário Oswaldo Cruz
Collaborator

Eligibility

Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children e adolescents aged 0 to 18 years; with cancer; undergoing chemotherapy/radiotherapy treatment; with oral mucositis greater than or equal to 2, according to the toxicity criteria of the World Health Organization (HUNTER, 1980)

Exclusion criteria

Exclusion criteria: Those included with a malignant neoplasm or severe infection (pseudomembranous candidiasis, herpes, etc.) clinically evident in the oral cavity; with solid tumors in the mouth or oropharynx; or in a serious situation that will prevent participation in the research will be excluded from the sample; in addition to these having allergic reactions to the composition of chamomile.

Design outcomes

Primary

MeasureTime frame
Clinical cure of the oral mucositis expressed by at least one point regretion on the World Health Organization (WHO) mucositis scale and pain absence registered on Children’s International Mucositis Evaluation Scale (ChIMES).

Secondary

MeasureTime frame
Secundary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactElizabeth Louisy da Silva
beth_louisy@hotmail.com+55 (81) 2126-8836

Outcome results

None listed

Source: REBEC (via WHO ICTRP)